Matches in Wikidata for { <http://www.wikidata.org/entity/Q58103455> ?p ?o ?g. }
- Q58103455 description "article scientifique publié en 2018" @default.
- Q58103455 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q58103455 description "bài báo khoa học" @default.
- Q58103455 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58103455 description "scientific article published on 29 October 2018" @default.
- Q58103455 description "wetenschappelijk artikel" @default.
- Q58103455 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q58103455 name "The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study" @default.
- Q58103455 name "The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study" @default.
- Q58103455 type Item @default.
- Q58103455 label "The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study" @default.
- Q58103455 label "The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study" @default.
- Q58103455 prefLabel "The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study" @default.
- Q58103455 prefLabel "The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study" @default.
- Q58103455 P1433 Q58103455-21498DDB-511A-4AE8-A610-61106DBE3BF5 @default.
- Q58103455 P1476 Q58103455-574087B7-2FB6-4FFC-92F4-5494EB117AB0 @default.
- Q58103455 P2093 Q58103455-0297D454-15F4-44D1-B425-A350493DA344 @default.
- Q58103455 P2093 Q58103455-15190D53-B851-4AEB-86C9-B61450C21CF6 @default.
- Q58103455 P2093 Q58103455-1CB43157-3CD7-43D1-8162-E06B73C1D84C @default.
- Q58103455 P2093 Q58103455-4976BE42-5F8B-499F-9B1F-1BB05D2A129B @default.
- Q58103455 P2093 Q58103455-689C4F78-8EE6-47F2-A668-F06E6EB45CD6 @default.
- Q58103455 P2093 Q58103455-68ECEE3A-8489-47A5-8700-44EECEFC5C80 @default.
- Q58103455 P2093 Q58103455-6C76F158-0D1D-46A1-ACC8-B7D2EB4E0806 @default.
- Q58103455 P2093 Q58103455-7C1E5A28-65E2-4D7E-9A83-0D259B12F93B @default.
- Q58103455 P2093 Q58103455-8B13FA1D-B91A-4800-9C38-B3795EAD372D @default.
- Q58103455 P2093 Q58103455-AAE3CB08-C849-42B3-88C6-E7C118311A78 @default.
- Q58103455 P2093 Q58103455-B58EA0F5-72F2-4348-97C0-09CF703D48EA @default.
- Q58103455 P2093 Q58103455-B9F4EEAF-2142-4974-8313-CDCEBE09156B @default.
- Q58103455 P2093 Q58103455-BD9DF970-C598-4FEB-9761-2D10AC50E2C7 @default.
- Q58103455 P2860 Q58103455-0DF7F4A5-F36A-4B42-A713-E9EBCB211AB7 @default.
- Q58103455 P2860 Q58103455-19EC8DA6-F794-4259-A32A-CB8CA240D507 @default.
- Q58103455 P2860 Q58103455-1A3A26B5-2BE3-445C-A20D-D69DBA18A6DB @default.
- Q58103455 P2860 Q58103455-1EFA3B50-9ADA-432C-9CAC-F609F4B950C8 @default.
- Q58103455 P2860 Q58103455-261A7DE1-66CA-4347-A1DA-CEAC61A4855C @default.
- Q58103455 P2860 Q58103455-29D2F73B-D345-47A6-BA48-C7839BCD6F91 @default.
- Q58103455 P2860 Q58103455-38733264-537C-4759-9AAF-34A6B0670B13 @default.
- Q58103455 P2860 Q58103455-42F87E86-EB4E-4733-BE28-6F8417B8201C @default.
- Q58103455 P2860 Q58103455-483AF8CF-2ACA-4A99-A060-C1E546337998 @default.
- Q58103455 P2860 Q58103455-5951DB8E-4A04-4275-B4FE-5A45147D8725 @default.
- Q58103455 P2860 Q58103455-640AA587-09DE-44D7-A002-969BD4A85198 @default.
- Q58103455 P2860 Q58103455-65155419-F3A5-4AE5-8E23-E1A59CCC094C @default.
- Q58103455 P2860 Q58103455-699450FC-83E5-4E89-AC16-B6AE7987017E @default.
- Q58103455 P2860 Q58103455-69FE663E-DB66-4836-B92E-945A96F103C5 @default.
- Q58103455 P2860 Q58103455-6AEFD93C-C250-40A7-A5CB-8A429D30574C @default.
- Q58103455 P2860 Q58103455-7866CA07-628A-43AF-9CD7-BF9A3FD6E5BB @default.
- Q58103455 P2860 Q58103455-7ADF10CA-1D05-441D-8875-C149C2D69CDE @default.
- Q58103455 P2860 Q58103455-854C5F2E-4754-4898-8C6F-59312EC43FF2 @default.
- Q58103455 P2860 Q58103455-8898A054-18B7-4741-9CF9-5A33E7022947 @default.
- Q58103455 P2860 Q58103455-99B9BD7A-E751-4EEA-B4B2-802A6BB05A27 @default.
- Q58103455 P2860 Q58103455-9B29903E-A54E-4C86-9FAC-4E04FFAEA4D2 @default.
- Q58103455 P2860 Q58103455-A73DA27C-6390-490C-8CC5-FA8590ACA87E @default.
- Q58103455 P2860 Q58103455-B3A1D3B3-417A-4BD6-946C-C607A2F682AA @default.
- Q58103455 P2860 Q58103455-C09C1BB4-FBFC-4CD3-B61A-EE3724117F55 @default.
- Q58103455 P2860 Q58103455-C399007C-9E15-4D69-91BF-2815A56F0CAA @default.
- Q58103455 P2860 Q58103455-C788B0B1-BE95-4224-90DE-AB1342D7DD8E @default.
- Q58103455 P2860 Q58103455-E0E8AB3F-3647-465C-A0C2-81A5DB894157 @default.
- Q58103455 P2860 Q58103455-E3E9AE38-2DE5-4536-8877-6EBA09A16C82 @default.
- Q58103455 P2860 Q58103455-EB25575F-490D-4B86-8986-5445FD5D4012 @default.
- Q58103455 P2860 Q58103455-FD3472D0-5898-41A3-8903-535DB71F4B0C @default.
- Q58103455 P304 Q58103455-EC7669E6-D866-462F-9D61-30C15168A0CE @default.
- Q58103455 P31 Q58103455-689BD379-EABA-4FBA-84CD-D1CCBA6FAA05 @default.
- Q58103455 P356 Q58103455-B4C76F48-5BF9-446B-94F1-1CAC048D948A @default.
- Q58103455 P407 Q58103455-15280786-1C04-4A06-83A0-773CFA8EC813 @default.
- Q58103455 P433 Q58103455-32DEAFDC-CA7E-459B-B4AB-20DB3C04366F @default.
- Q58103455 P478 Q58103455-55F1995F-EDF4-4D86-97EC-9E830BB8853C @default.
- Q58103455 P50 Q58103455-37DA9C4F-DF03-4962-A5C3-1894BDBFE1FF @default.
- Q58103455 P577 Q58103455-B37B6268-5AF7-41C1-9C56-FAEEF25A4601 @default.
- Q58103455 P698 Q58103455-D33EC57C-2CEE-4315-A1FD-E64F65E2E24A @default.
- Q58103455 P921 Q58103455-FCEB5F31-8080-410B-9B45-8F5AE817046D @default.
- Q58103455 P921 Q58103455-FD521EF1-9F95-4AA9-B93C-C9AC21F91EDA @default.
- Q58103455 P356 S10147-018-1361-9 @default.
- Q58103455 P698 30374686 @default.
- Q58103455 P1433 Q15758148 @default.
- Q58103455 P1476 "The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study" @default.
- Q58103455 P2093 "Angelos Koutras" @default.
- Q58103455 P2093 "Aristotelis Bamias" @default.
- Q58103455 P2093 "Epaminontas Samantas" @default.
- Q58103455 P2093 "Euthymios Kostouros" @default.
- Q58103455 P2093 "Flora Zagouri" @default.
- Q58103455 P2093 "George Fountzilas" @default.
- Q58103455 P2093 "Gerasimos Aravantinos" @default.
- Q58103455 P2093 "Ioannis Gkerzelis" @default.
- Q58103455 P2093 "Kimon Tzannis" @default.
- Q58103455 P2093 "Konstantinos Koutsoukos" @default.
- Q58103455 P2093 "Meletios-Athanasios Dimopoulos" @default.
- Q58103455 P2093 "Nikolaos Gavalas" @default.
- Q58103455 P2093 "Vasilios Karavasilis" @default.
- Q58103455 P2860 Q22009936 @default.
- Q58103455 P2860 Q28282757 @default.
- Q58103455 P2860 Q29615445 @default.
- Q58103455 P2860 Q29615711 @default.
- Q58103455 P2860 Q29618031 @default.
- Q58103455 P2860 Q34586436 @default.
- Q58103455 P2860 Q34650664 @default.
- Q58103455 P2860 Q35052385 @default.
- Q58103455 P2860 Q35144490 @default.
- Q58103455 P2860 Q35879398 @default.
- Q58103455 P2860 Q35943769 @default.
- Q58103455 P2860 Q36281483 @default.
- Q58103455 P2860 Q37172098 @default.